Aurinia Pharmaceuticals, Inc. (AUPH)
15.68
+0.06
(+0.38%)
USD |
NASDAQ |
Dec 08, 16:00
15.56
-0.12
(-0.77%)
After-Hours: 20:00
Aurinia Pharmaceuticals Shareholders Equity (Quarterly): 365.77M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Halozyme Therapeutics, Inc. | 503.92M |
| Oncolytics Biotech, Inc. | 0.0827M |
| Edesa Biotech, Inc. | 14.13M |
| Lexaria Bioscience Corp. | 2.990M |
| Xenon Pharmaceuticals, Inc. | 559.51M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 527.53M |
| Total Liabilities (Quarterly) | 161.76M |
| Debt to Equity Ratio | 0.2138 |
| Current Ratio | 5.756 |
| Net Debt Paydown Yield | 0.11% |